| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
|
Gastroenterology
|
2008
|
3.82
|
|
2
|
A prospective nationwide study of drug-induced liver injury in Korea.
|
Am J Gastroenterol
|
2012
|
2.43
|
|
3
|
Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease.
|
Thromb Res
|
2006
|
1.63
|
|
4
|
Revision and update on clinical practice guideline for liver cirrhosis.
|
Korean J Hepatol
|
2012
|
1.47
|
|
5
|
[Factors associated with liver stiffness in chronic liver disease].
|
Korean J Hepatol
|
2009
|
1.44
|
|
6
|
Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine.
|
Liver Int
|
2010
|
1.43
|
|
7
|
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B.
|
Hepatology
|
2007
|
1.33
|
|
8
|
Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments.
|
J Hepatol
|
2004
|
1.32
|
|
9
|
Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
|
Gene
|
2012
|
1.30
|
|
10
|
Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.
|
Hepatology
|
2011
|
1.29
|
|
11
|
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression.
|
Hepatology
|
2007
|
1.21
|
|
12
|
Bowel obstruction caused by an intramural duodenal hematoma: a case report of endoscopic incision and drainage.
|
J Korean Med Sci
|
2009
|
1.21
|
|
13
|
Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population.
|
Mol Carcinog
|
2012
|
1.13
|
|
14
|
Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study.
|
Gut Liver
|
2012
|
1.08
|
|
15
|
Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea.
|
J Med Virol
|
2010
|
1.02
|
|
16
|
Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
|
Gene
|
2013
|
1.01
|
|
17
|
Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis.
|
Dig Dis Sci
|
2010
|
0.99
|
|
18
|
Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer.
|
Anticancer Res
|
2007
|
0.96
|
|
19
|
Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea.
|
Anticancer Res
|
2008
|
0.95
|
|
20
|
Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.
|
Clin Mol Hepatol
|
2013
|
0.94
|
|
21
|
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population.
|
Anticancer Res
|
2005
|
0.94
|
|
22
|
Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.
|
Mol Carcinog
|
2012
|
0.92
|
|
23
|
[The efficacy of levofloxacin based triple therapy for Helicobacter pylori eradication].
|
Korean J Gastroenterol
|
2006
|
0.91
|
|
24
|
Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine.
|
Vaccine
|
2012
|
0.88
|
|
25
|
Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
|
Anticancer Res
|
2008
|
0.87
|
|
26
|
Acute hepatitis C in Korea: different modes of infection, high rate of spontaneous recovery, and low rate of seroconversion.
|
J Med Virol
|
2011
|
0.87
|
|
27
|
Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans.
|
Anticancer Res
|
2010
|
0.85
|
|
28
|
The complete genome sequence and molecular analysis of human hepatitis E virus genotype IV identified from a Korean patient.
|
Arch Virol
|
2010
|
0.85
|
|
29
|
Occult hepatitis B virus infection in pregnant woman and its clinical implication.
|
Liver Int
|
2008
|
0.85
|
|
30
|
Hepatitis A virus genotype and its correlation with the clinical outcome of acute hepatitis A in Korea: 2006-2008.
|
J Med Virol
|
2011
|
0.85
|
|
31
|
Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population.
|
BMC Gastroenterol
|
2013
|
0.84
|
|
32
|
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy.
|
J Gastroenterol
|
2010
|
0.84
|
|
33
|
Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population.
|
Anticancer Res
|
2007
|
0.84
|
|
34
|
Fatal biliary-systemic air embolism during endoscopic retrograde cholangiopancreatography: a case with multifocal liver abscesses and choledochoduodenostomy.
|
Yonsei Med J
|
2010
|
0.84
|
|
35
|
Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer.
|
Yonsei Med J
|
2008
|
0.83
|
|
36
|
A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
|
Hepatogastroenterology
|
2012
|
0.83
|
|
37
|
Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.
|
Gut Liver
|
2012
|
0.83
|
|
38
|
[A case of combined hepatocellular-cholangiocarcinoma with sarcomatous transformation and second primary colon cancer].
|
Korean J Hepatol
|
2004
|
0.83
|
|
39
|
[Validation of the Korean version of liver disease quality of life (LDQOL 1.0) instrument].
|
Korean J Hepatol
|
2007
|
0.83
|
|
40
|
[Clinical outcomes after discontinuation of Lamivudine in chronic hepatitis B patients with Lamivudine resistant HBV mutant].
|
Korean J Hepatol
|
2005
|
0.82
|
|
41
|
The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy.
|
Yonsei Med J
|
2011
|
0.82
|
|
42
|
Associations of Expressions of HBcAg and HBsAg with the Histologic Activity of Liver Disease and Viral Replication.
|
Gut Liver
|
2008
|
0.82
|
|
43
|
[Abnormal liver function tests in pregnancy: a single institution experience].
|
Korean J Gastroenterol
|
2007
|
0.82
|
|
44
|
Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B.
|
Clin Biochem
|
2012
|
0.81
|
|
45
|
Development and validation of a model to predict advanced fibrosis in chronic hepatitis B virus-infected patients with high viral load and normal or minimally raised ALT.
|
Dig Dis Sci
|
2010
|
0.81
|
|
46
|
[Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B].
|
Korean J Hepatol
|
2008
|
0.81
|
|
47
|
Usefulness of multiple biomarkers for the prediction of significant fibrosis in chronic hepatitis B.
|
J Clin Gastroenterol
|
2011
|
0.81
|
|
48
|
[The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
|
Taehan Kan Hakhoe Chi
|
2003
|
0.80
|
|
49
|
Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C.
|
Dig Dis Sci
|
2010
|
0.80
|
|
50
|
Molecular epidemiology of hepatitis A virus in the South-East area of Gyeonggi-do in Korea.
|
Yonsei Med J
|
2009
|
0.79
|
|
51
|
Polymorphisms of folate metabolism-related genes and survival of patients with colorectal cancer in the Korean population.
|
Gene
|
2013
|
0.79
|
|
52
|
Prevalence of occult hepatitis B virus infection in hemodialysis patients.
|
Korean J Gastroenterol
|
2013
|
0.79
|
|
53
|
Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.
|
Clin Mol Hepatol
|
2013
|
0.79
|
|
54
|
Effects of metabolic syndrome on fibrosis in chronic viral hepatitis.
|
Gut Liver
|
2013
|
0.78
|
|
55
|
[The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
|
Korean J Hepatol
|
2007
|
0.78
|
|
56
|
[Clinical significance of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in Korean patients with gastric cancer].
|
Korean J Gastroenterol
|
2005
|
0.77
|
|
57
|
Hepatitis B core antigen expression in hepatocytes reflects viral response to entecavir in chronic hepatitis B patients.
|
Gut Liver
|
2013
|
0.77
|
|
58
|
Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy?
|
Clin Biochem
|
2010
|
0.77
|
|
59
|
Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
|
J Med Virol
|
2015
|
0.77
|
|
60
|
Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.
|
Scand J Gastroenterol
|
2012
|
0.77
|
|
61
|
Efficacy and safety of human placental extract for alcoholic and nonalcoholic steatohepatitis: an open-label, randomized, comparative study.
|
Biol Pharm Bull
|
2014
|
0.76
|
|
62
|
The usefulness of angiotensin converting enzyme in the differential diagnosis of Crohn's disease and intestinal tuberculosis.
|
Korean J Intern Med
|
2007
|
0.76
|
|
63
|
[Occult hepatitis B virus infection: transmission and reactivation].
|
Korean J Gastroenterol
|
2013
|
0.76
|
|
64
|
Diagnostic value of multiple biomarker panel for prediction of significant fibrosis in chronic hepatitis C.
|
Clin Biochem
|
2011
|
0.76
|
|
65
|
[Liver stiffness measurement for the diagnosis of hepatic fibrosis in patients with chronic viral hepatitis].
|
Korean J Hepatol
|
2007
|
0.76
|
|
66
|
An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
67
|
Characterization of antiphospholipid antibodies in chronic hepatitis B infection.
|
Korean J Hematol
|
2011
|
0.75
|
|
68
|
Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection.
|
J Clin Virol
|
2013
|
0.75
|
|
69
|
[Clinical characteristics of health screen examinees with nonalcoholic fatty liver and normal liver function test].
|
Korean J Gastroenterol
|
2008
|
0.75
|
|
70
|
[A case of hemophagocytic syndrome with terminal ileal ulcerations].
|
Korean J Gastroenterol
|
2006
|
0.75
|
|
71
|
[Prevention of hepatocellular carcinoma].
|
Korean J Gastroenterol
|
2007
|
0.75
|
|
72
|
[Hepatitis B and C virus infection and liver dysfunction in patients receiving chemotherapy].
|
Korean J Gastroenterol
|
2006
|
0.75
|